Of note, in hypercholesterolemic mice, atherosclerosis was accelerated by administration of LDL-induced DCs and attenuated by immunotherapy with DCs treated with ApoB100 and IL-10, indicating that atherosclerosis could be modulated by modifying the maturation of DCs [23, 62]. This evidence concerns the gene IL10 and atherosclerosis.